Stockreport

Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case [Yahoo! Finance]

United Therapeutics Corporation  (UTHR) 
Last united therapeutics corporation earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.unither.com/investor-relations
PDF to Jim Simons' Renaissance Technologies . On October 2, Jefferies reiterated its “Buy” rating and a price target of $564 for United Therapeutics Corporation (NASDAQ:UTHR [Read more]